Check-Cap, the Israel-based developer of the first non-invasive, prep-free imaging test for colon cancer, received an undisclosed sum from General Electric’s healthcare and venturing divisions, GE Healthcare and GE Capital, on 1st February. The investment was made through GE’s Healthymagination fund. The funding comes less than a year after Check-Cap pulled in NIS 35m ($9.8m)…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
